NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Apr 9, 2020-- Lantheus Holdings, Inc. (NASDAQ: LNTH) (`Lantheus` or the `Company`), parent company of Lantheus Medical Imaging, Inc. (`LMI`), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents announced today that its preliminary unaudited revenue for the fiscal first quarter ended March 31, 2020 will be near the top end of previously disclosed guidance range issued on February 25, 2020. `For the first quarter of 2020, business results through the first two months were ahead of Company expectations,` said Mary Anne Heino, President and CEO. `However, as COVID-19 reached a global pandemic level in...
|
